340B Drug Discount Program

New CHA Infographic Available on 340B Drug Pricing Program

What’s happening: CHA's new infographic illustrates how the 340B program works, highlights its benefits to patients and communities in reducing drug costs and expanding access to care, details who is eligible to participate, and sets the record straight on program oversight and compliance. 

HHS Takes Initial Step Toward Restarting Review Process for 340B Rebate Model

What's happening: The Department of Health and Human Services (HHS) has taken a step toward restarting the administrative process for establishing a 340B rebate model, filing a notice with the Office of Management and Budget that it will look to publish an advance notice of proposed rulemaking. The timing of a proposed rule is unclear at this time, but CHA will keep members apprised of any new administrative process that is put forward.  

CHA Files Amicus Brief Opposing Drug Manufacturers’ Lawsuits Over 340B Rebate Models

This post has been archived and contains information that may be out of date.

What’s happening: CHA has filed an amicus (“friend of the court”) brief with 36 other state and regional hospital associations supporting the Health Resources and Services Administration (HRSA) against pharmaceutical manufacturers’ appeal of rulings related to 340B Drug Pricing Program rebate models.